help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism , doi:10.1210/jc.2008-2572
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Google Scholar
Right arrow Articles by Mayan, H.
Right arrow Articles by Farfel, Z.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mayan, H.
Right arrow Articles by Farfel, Z.
Related Collections
Right arrow Calcium and Bone Metabolism
The Journal of Clinical Endocrinology & Metabolism Vol. 94, No. 8 3010-3016
Copyright © 2009 by The Endocrine Society

Familial Hyperkalemia and Hypertension: Pathogenetic Insights Based on Lithium Clearance

Haim Mayan, Semyon Melnikov, Ilya Novikov, Eliezer J. Holtzman and Zvi Farfel

Department of Medicine E (H.M., Z.F.), Laboratory of Biochemical Pharmacology (S.M., Z.F.), Laboratory of Molecular Nephrology (E.J.H), and Gertner Institute of Epidemiology (I.N.), Sheba Medical Center, Sackler School of Medicine, Tel Aviv University, Tel Hashomer, Israel 52621

Address all correspondence and requests for reprints to: Zvi Farfel M.D., Department of Medicine E, Sheba Medical Center, Tel Hashomer, Israel 52621. E-mail: farfel{at}post.tau.ac.il.

Context: Familial hyperkalemia and hypertension (FHHt) is caused by mutations in WNK kinases. Its pathogenesis is not completely understood.

Objective: Our objective was to investigate the mechanism of hypercalciuria in FHHt.

Design and Setting: We conducted a study of a large family with FHHt and WNK4 Q565E mutation and of control subjects at a referral medical center.

Subjects: Forty-six members of a family with FHHt and WNK4 Q565E mutation, 23 of them affected, and 12 control subjects participated.

Main Outcome Measures: Urinary calcium and sodium concentrations, endogenous lithium clearance, age of hypertension appearance were assessed.

Results: In 40 urine samples of 20 affected subjects, urinary calcium was correlated to urinary sodium (r = 0.567; P = 0.0001). In 28 urinary samples of 22 unaffected members, no correlation was found (r = 0.285; P = 0.14). Mean ratio of urinary calcium to urinary sodium was 2.7-fold higher in affected compared with unaffected members (58.7 ± 25.9 vs. 22.1 ± 14.0 µmol/mmol, P < 0.0001). Endogenous lithium clearance in eight affected members was about 50% lower than in 12 controls (16.2 ± 7.7 vs. 28.8 ± 9.8 ml/min, P = 0.0073). Hypertension was detected in males 12 yr earlier than in females (26.0 ± 7.5 vs. 37.9 ± 11.3 yr; P = 0.031).

Conclusions: Hypercalciuria in FHHt seems to be dependent on urinary sodium. According to molecular studies, FHHt patients are presumed to have increased distal nephron sodium reabsorption and therefore decreased proximal reabsorption of sodium, lithium, and calcium. The observed decreased lithium clearance reflects probable abnormal renal handling of lithium, i.e. distal nephron lithium reabsorption. Therefore, hypercalciuria may result from proximal nephron aberration. Finally, earlier appearance of hypertension in males may be the result of sex-hormone activity.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2009 by The Endocrine Society